The High-Dose Melatonin Protocol: Dosing, Evidence, and Safety

High-dose melatonin is the clinical use of melatonin at doses substantially above the 0.5 to 5 mg range typically used for sleep, commonly 20 mg to 200 mg or more, administered for melatonin's antioxidant and mitochondrial effects rather than for sedation.

Ask most people what melatonin does and they will tell you it helps you sleep. That is true, and it is the least interesting thing about the molecule. This page covers what high-dose melatonin actually is, what doses have been studied, what the evidence supports, and, critically, who should not take it.

Why would anyone take 100 mg of melatonin instead of 3 mg?

Because the two doses are being used for entirely different purposes.

At 0.5 to 5 mg, melatonin acts on the MT1 and MT2 receptors to shift circadian timing. This is a signalling effect, and like most signalling effects it saturates: once the receptors are occupied, more melatonin does not produce more signal. This is why taking 20 mg for sleep does not work better than taking 3 mg, and why people who escalate their sleep dose are usually disappointed.

Melatonin's other actions work by a different mechanism entirely. It is a direct free-radical scavenger and it supports mitochondrial function, and these effects are not receptor-mediated. They are concentration-dependent. Saturating tissue and mitochondrial compartments requires substantially more melatonin than saturating a receptor does.

Animal studies demonstrating robust mitochondrial protection typically use doses that, adjusted for body weight and metabolism, correspond to roughly 50 to 100 mg or more in a human. A person taking 100 mg of melatonin is not trying to sleep harder. They are pursuing a different pharmacology.

What does the safety evidence actually show?

The safety literature on high-dose melatonin is reassuring, but it is thinner than enthusiasts often imply, and honesty about that gap matters.

The most important reference is a 2022 systematic review and meta-analysis by Menczel Schrire and colleagues, published in the Journal of Pineal Research, which examined the safety of higher melatonin doses in adults. It found that doses in the 20 to 100 mg range were generally well tolerated.

Supporting this: Phase 1 pharmacological studies in healthy volunteers have tested melatonin at doses up to 100 mg without significant toxicity. A 2025 analysis published in Brain Sciences examined 81 patients treated with melatonin at 40 to 200 mg daily.

Across this literature, reported adverse effects at high doses are predominantly mild sedation, dizziness, and headache. Serious adverse events are rare, and adverse effects are generally self-limiting or resolve quickly on discontinuation.

What that evidence does not establish: most of these trials are short-term. Long-term safety data above 100 mg are genuinely limited. Well tolerated in trials lasting weeks is not the same claim as safe indefinitely, and anyone telling you otherwise is overselling.

How much melatonin is too much?

There is no established toxic dose of melatonin in adults. Melatonin has a remarkably wide safety margin, which is precisely why it has been possible to study it at doses hundreds of times higher than the sleep dose.

In practice, the ceiling is not toxicity. It is sedation. Long before you approach anything resembling a dangerous dose, you will encounter next-day grogginess that most people find limiting. That is the real constraint, and it is a feature of the molecule, not a side effect to be engineered away.

The honest framing: the absence of a known toxic dose is not the same thing as proof of long-term safety at high doses. Those are different claims, and the evidence supports the first far more strongly than the second.

Who should not take high-dose melatonin?

Do not take high-dose melatonin if you will drive or operate machinery within roughly 8 to 10 hours. This is the single most practical safety point on this page. The impairment is real.

Approach with caution and clinical guidance if you are pregnant or breastfeeding; taking anticoagulants, immunosuppressants, or anticonvulsants; living with an autoimmune condition; taking blood pressure or diabetes medication, both of which melatonin can interact with; or a child or adolescent, in whom high-dose data are essentially absent.

If you take prescription medication of any kind, speak with a clinician before beginning a high-dose protocol. This is not boilerplate. Melatonin is pharmacologically active at these doses, and pharmacologically active substances interact.

What about the delivery method?

Oral melatonin undergoes substantial first-pass metabolism in the liver, meaning a large fraction of an oral dose is broken down before it reaches systemic circulation. Reported oral bioavailability varies widely between individuals.

This is the reason alternative delivery routes, including suppository, intranasal, liposomal, and transdermal, are of clinical interest at high doses: they bypass or reduce first-pass metabolism, so a given milligram figure delivers more melatonin to circulation.

The practical implication is one that gets lost in most discussions: a milligram number means little without the route attached. 100 mg orally and 100 mg rectally are not the same exposure. Comparing dose figures across delivery methods, as is common in online discussion, produces confusion rather than insight.

References and further reading

Menczel Schrire Z, Phillips CL, Chapman JL, et al. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. Journal of Pineal Research. 2022;72(2):e12782.

Rethinking Melatonin Dosing: Safety and Efficacy at Higher-than-Usual Levels in Aged Patients with Sleep Disturbances and Comorbidities. Brain Sciences. 2025;15(10):1040.

Dr. John Lieurance is the author of Melatonin: Miracle Molecule (ISBN 979-8429848211).

Medical disclaimer. This article is educational and does not constitute medical advice. Melatonin is not FDA-approved for the uses discussed here. Doses described reflect what has been examined in the cited literature and are not a recommendation. Consult a qualified clinician before beginning any high-dose protocol. Reviewed by Dr. John Lieurance, DC, ND.